A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia

To evaluate single‐voxel proton magnetic resonance spectroscopy (SV‐MRS) and magnetic resonance spectroscopic imaging (MRSI) metabolite results in individuals with HIV dementia.

[1]  A Ebel,et al.  Assessment of 3D proton MR echo‐planar spectroscopic imaging using automated spectral analysis , 2001, Magnetic resonance in medicine.

[2]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[3]  I. Wilkinson,et al.  A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. , 1996, AIDS research and human retroviruses.

[4]  P. Barker,et al.  N‐Acetyl Aspartate—A Neuronal Marker? , 2001, Annals of neurology.

[5]  P. Barker,et al.  AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.

[6]  R. Kuzniecky,et al.  Reproducibility of Proton Magnetic Resonance Spectroscopy Imaging Measurements of Normal Human Hippocampus at 1.5 T: Clinical Implications , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[7]  Oded Gonen,et al.  Reproducibility of 3D proton spectroscopy in the human brain , 2002, Magnetic resonance in medicine.

[8]  T. Ernst,et al.  Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe , 1996, Magnetic resonance in medicine.

[9]  Alessandro Bertolino,et al.  Reproducibility of Proton Magnetic Resonance Spectroscopic Imaging in Patients with Schizophrenia , 1998, Neuropsychopharmacology.

[10]  T. Ogino,et al.  Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains. , 1999, Radiation medicine.

[11]  L. Bérubé,et al.  [Clinical neuropsychology]. , 1982, Nursing Quebec.

[12]  L. Chang,et al.  Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex , 1999, Neurology.

[13]  David H. Miller,et al.  Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[14]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[15]  Cheuk Y. Tang,et al.  A multi‐center 1H MRS study of the AIDS dementia complex: Validation and preliminary analysis , 2003, Journal of magnetic resonance imaging : JMRI.

[16]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.

[17]  L. Wilkins.  Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder , 1996, Neurology.

[18]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .

[19]  D P Auer,et al.  On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.

[20]  G B Matson,et al.  Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability. , 2001, Magnetic resonance imaging.

[21]  Y. Hsu,et al.  Reproducibility of hippocampal single-Voxel proton MR spectroscopy and chemical shift imaging. , 2001, AJR. American journal of roentgenology.

[22]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[23]  L. Prockop.  AIDS dementia complex. , 1988, The Journal of legal medicine.

[24]  K. Marder,et al.  Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment , 2003, Neurology.

[25]  E Moser,et al.  Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.

[26]  B J Soher,et al.  Quantitation of automated single‐voxel proton MRS using cerebral water as an internal reference , 1996, Magnetic resonance in medicine.

[27]  G. di Chiro,et al.  Reproducibility of proton MR spectroscopic imaging findings. , 1996, AJNR. American journal of neuroradiology.

[28]  S F Keevil,et al.  Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. , 1998, Magnetic resonance imaging.

[29]  H C Charles,et al.  Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain , 1996, Magnetic resonance in medicine.

[30]  W M Brooks,et al.  Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.

[31]  D. Menon,et al.  Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.

[32]  B J Soher,et al.  Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.

[33]  I. Marshall,et al.  Reproducibility of metabolite peak areas in 1H MRS of brain. , 1996, Magnetic resonance imaging.

[34]  P A Narayana,et al.  Short TE hydrogen‐1 spectroscopic MR imaging of normal human brain: Reproducibility studies , 1994, Journal of magnetic resonance imaging : JMRI.